Navigation Links
AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
Date:9/5/2007

tenance opioid therapy. The first part of the trial was a single arm, open-label dose titration to evaluate the effective individual dose for significant pain relief with Fentanyl TAIFUN(R) in the treatment of breakthrough cancer pain. The second part included responders from the open-label part randomized to receive the titrated doses or placebo.

Chronic pain associated with advanced cancer is commonly treated with strong opioid analgesics, such as fentanyl. Breakthrough pain episodes are sudden and intense flares of pain that "break through" a long-acting continuous treatment, such as a transdermal patch or a slow release tablet. Breakthrough pain episodes are common in cancer patients, often occurring several times a day.

Conference call information:

Akela will host a conference call at 11:00 am, on Wednesday September 5, 2007. Interested parties may also access the conference call by webcast at http://www.akelapharma.com.

The telephone number to access the conference call is 1-800-731-5319. A replay of the call will be available until Wednesday September 12, 2007. The telephone numbers to access the replay are 416-640-1917 and 1-877-289-8525 with code number 21245927#.

About Akela Pharma Inc.

Akela Pharma is an integrated drug development company focused on developing therapies for the growing multi-billion dollar inhalation, pain and CNS markets. Its lead product, for the treatment of breakthrough cancer pain, is a fast-acting Fentanyl formulation delivered using the Company's TAIFUN(R) dry powder inhaler platform. Its pipeline also includes therapeutics for asthma, COPD, growth hormone deficiencies and controlled substance abuse deterrent formulations.

Akela's common shares trade on The Toronto Stock Exchange ("TSX") under the symbol "AKL" with 82.3 million shares outstanding.

This news release contains certain forward-looking statements that reflect the curr
'/>"/>

SOURCE AKELA PHARMA INC.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. India to benefit from pharma companies move
2. South Africa Wins landmark case against pharmaceutical giants
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
5. Pharma cos must forge Strategic alliances
6. Setting up a new pharmaceutical industry in India
7. Medicis Pharmaceutical company enters pediatric market
8. Supply of Radiopharmaceuticals Hampered by Attacks
9. Pharma majors gear to supply anti-anthrax drug
10. Pharmacies in for a dose of bitter medicine
11. Andhra Pradesh to set up Pharma City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... places, and to do everything from growing mushrooms, making wine to keeping ... ... have thought that your wine, water and vegetables would have come from ... line of turbines, for industry end users, not wind farms. "Using ...
(Date:12/4/2009)... Care Investment Trust Inc. (NYSE: CRE ) ... has declared a dividend of $0.17 per share of common stock. ... shareholders of record on December 14, 2009. ,, ... is a real estate investment and finance company investing in healthcare-related ...
(Date:12/4/2009)... 4 Medithrive, Inc. has won the Patient,s Choice ... Area by popular vote conducted by the online website, ... the SF Bay community has selected Medithrive as the ... The rapid rise and popularity of Medithrive confirms the ...
(Date:12/4/2009)... of Homes and Services for the Aging (AAHSA) applauds the ... Services (CLASS) provisions remain in the final health reform legislation ... elders, people with disabilities and their caregivers. ,, We ... that will make it affordable to care for families and ...
(Date:12/4/2009)... KANSAS CITY, Mo., Dec. 4 The large, two-day free ... (NAFC) in Kansas City on Wednesday and Thursday is not ... uninsured and has not seen a doctor recently. All participants ... ,, "Many people who attended the three previous large free ...
Breaking Medicine News(10 mins):Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Free Health Clinic Event Is Not Just for the Sick 2
... Exhibit, ... March 25-26, 2008, WASHINGTON, Dec. ... judges has selected the finalists for its,inaugural Best Practices in Consumer ... proven programs that are enhancing patient safety and giving,consumers more control ...
... Rehabilitation Centers of,America, Inc. (Navitas), the market ... services, is pleased to announce that,its Denver, ... campus of Presbyterian/St.,Luke,s Medical Center. Navitas has ... Luke,s to provide its proprietary cancer,rehabilitation program ...
... in unprotected sex, but with those already carrying the virus ... infected with HIV (the virus that causes AIDS) choose to ... researchers who analyzed data from six clinics in San Francisco, ... Providence, R.I. , The study included 27 men with acute ...
... million Americans, Osteoarthritis of the knee (OA) is one ... elderly. While OA mainly affects most people over ... placebo-controlled study published in the journal Nutrition Research reveals ... of the French maritime pine tree, improved physical function ...
... In about 20 percent of women with breast cancer ... imaging reveals important diagnostic information that alters their treatment ... , This study was presented at the 119th annual ... in Hot Springs, Va., and will appear in the ...
... typical in later years, study suggests , , WEDNESDAY, Nov. ... the biological underpinnings of "senior moments," new research shows ... to break down as a person grows older. , ... cognition in normal aging," said lead researcher Randy Buckner, ...
Other Medicine News:Health News:URAC Names Sensei for Weight Loss as a Finalist in First-Ever Best Practices in Consumer Empowerment and Protection Awards 2Health News:URAC Names Sensei for Weight Loss as a Finalist in First-Ever Best Practices in Consumer Empowerment and Protection Awards 3Health News:Navitas Opens Cancer Rehabilitation Center in Denver in Conjunction With Presbyterian / St. Luke's Medical Center 2Health News:Navitas Opens Cancer Rehabilitation Center in Denver in Conjunction With Presbyterian / St. Luke's Medical Center 3Health News:Newly HIV-Infected Gay Men Select Other Infected Partners 2Health News:Study shows pine bark naturally reduces osteoarthritis knee pain 2Health News:Study shows pine bark naturally reduces osteoarthritis knee pain 3Health News:Breast MRI spots other cancers, may alter treatment plan 2Health News:Breast MRI spots other cancers, may alter treatment plan 3Health News:Breast MRI spots other cancers, may alter treatment plan 4Health News:Aging Brains Get Out of Sync 2Health News:Aging Brains Get Out of Sync 3
(Date:12/4/2009)... Watson Pharmaceuticals, Inc. (NYSE: WPI ), ... its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New ... Administration seeking approval to market its 8mg ramelteon tablets ... Takeda Pharmaceutical Company Limited. Watson,s 8mg ramelteon tablet ...
(Date:12/4/2009)... 4 Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") ... Patent and Trademark Office has allowed its patent application ... of the manufacture of the Company,s DCVax® therapeutic cancer ... the very high concentration of dendritic cells (which are ...
(Date:12/3/2009)... , a leading primary research firm, today announced the launch ... that monitors and projects trends and market share in the ... captures actual patient usage for 87 different Sleep Apnea mask ... providers going back to January 2006. In the most ...
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2First World Congress on Positive Psychology Kicks Off With Talks by Two of the Worlds Most Renowned Psychologists 47746 1First World Congress on Positive Psychology Kicks Off With Talks by Two of the Worlds Most Renowned Psychologists 47746 2First World Congress on Positive Psychology Kicks Off With Talks by Two of the Worlds Most Renowned Psychologists 47746 3Audi Teamed Up With Star Quarterback Tom Brady and Celebrities to Support People With Intellectual Disabilities 47742 1Audi Teamed Up With Star Quarterback Tom Brady and Celebrities to Support People With Intellectual Disabilities 47742 2Audi Teamed Up With Star Quarterback Tom Brady and Celebrities to Support People With Intellectual Disabilities 47742 3ATS Medical Announces Participation in the International Society for Minimally Invasive Cardiothoracic Surgery Meeting 47739 1ATS Medical Announces Participation in the International Society for Minimally Invasive Cardiothoracic Surgery Meeting 47739 2ATS Medical Announces Participation in the International Society for Minimally Invasive Cardiothoracic Surgery Meeting 47739 3ATS Medical Announces Participation in the International Society for Minimally Invasive Cardiothoracic Surgery Meeting 47739 4
... provider of clinical services and trial management technologies for ... along with its client Genentech, Inc as the winner ... Clinical Trial Portal solution. Winners were selected from ... panel of 14 expert judges. The ePharmaSolutions Clinical ...
... Using a steroid drug for multiple sclerosis (MS) in ... disease activity more than using the MS drug alone, according ... Program at the American Academy of Neurology,s 61st Annual Meeting ... the study, people with MS received the steroid drug methylprednisolone ...
Other Medicine Technology:ePharmaSolutions' Clinical Trial Investigator Portal Wins Bio-IT World 2009 Best Practice Award 2Adding Steroid Drug to MS Treatment May Reduce Disease Activity 2
... IEC-Innovative Endoscopy Components, LLC ... Medical Equipment "Made in ... are manufactured according to ... the most excellent design ...
... sensitive DR system. It features a 17 ... designed for most general radiographic applications. Versatile ... stand and table configurations. , ,With ... detailed patient images with reduced dose. The ...
... to provide the surgeon with an optimal work ... during cataract and retinal surgery. Perfect Pupil Injectable ... sized pupils which allows expansion of the pupil ... surgery, and allows the pupil to return to ...
... remove bone cement speedily and efficiently. , ,The ... at the point of contact, allowing it to ... of the apparatus is its ability to recognize ... the operator instantly. Probe position can thus be ...
Medicine Products: